Therefore, the potential of nutraceutical approaches such as administration of casein hydrolysates and n-3 LC-PUFAs to enhance adiponectin circulating levels are worth exploring further to determine if they may represent a useful and therapeutic strategy to fight and prevent obesity-related disorders. Here, ADIPOQ is linked to obesity disorder.